Milan, Italy

Jonathan S Dando



Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 54(Granted Patents)


Location History:

  • Sunnyvale, CA (US) (1999)
  • Milan, IT (2000)

Company Filing History:


Years Active: 1999-2000

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Jonathan S Dando

Introduction

Jonathan S Dando is a notable inventor based in Milan, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing retroviral vectors. With a total of 2 patents, his work has implications for gene therapy applications.

Latest Patents

Dando's latest patents include a method for obtaining retroviral packaging cell lines that produce high levels of retroviral vectors. This invention provides a comprehensive approach to creating recombinant retroviral packaging cells capable of producing retroviral vectors. The method involves introducing a recombinant retroviral vector into the packaging cells and propagating the resulting producer cells under conditions that favor the production and secretion of retroviral vector supernatant. Additionally, the invention includes methods for screening retroviral vector supernatant for high transduction efficiency, which is crucial for effective gene therapy applications.

Career Highlights

Jonathan S Dando is currently associated with Systemix, Inc., where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing the understanding and application of retroviral vectors in medical research and therapy.

Collaborations

Dando has collaborated with notable colleagues such as Richard J Rigg and Jingyi Chen, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Jonathan S Dando's contributions to the field of biotechnology, particularly through his patents and collaborations, highlight his role as a significant inventor in the realm of gene therapy. His innovative methods for producing retroviral vectors are paving the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…